Bayer Cropscience · NSE: BAYERCROP · BSE: 506285
Q4 FY21 results · Jan–Mar 2021
Bayer Cropscience reported revenue from operations of ₹733.70 crore (up 60.0% from Q4 FY20) and net profit of ₹61.90 crore (up 96.5% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a standalone basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 733.70 | 458.70 | +60.0% | 918.20 | −20.1% |
| Other income | 15.90 | 17.80 | −10.7% | 18.30 | −13.1% |
| Total income | 749.60 | 476.50 | +57.3% | 936.50 | −20.0% |
| Profit before tax | 79.80 | 25.70 | +210.5% | 106.10 | −24.8% |
| Net profit for the period | 61.90 | 31.50 | +96.5% | (45.10) | Turned profit |
| EPS, basic (₹) | 13.77 | 7.01 | +96.4% | (10.03) | Turned profit |
| Net margin (%) | 8.4 | 6.9 | -4.9 |
Standalone
- Filed with BSE
- 26 May 2021, 19:35 IST
- Board meeting
- 25 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE